New three-dimensional preclinical models to understand and treat liver cancers activated for the β-catenin pathway
This study establishes a robust, dynamic suspension culture method using rotating bioreactors to generate uniform, viable 3D organoids and tumouroids from mouse models of beta-catenin-activated liver cancers, which successfully recapitulate native tissue features and demonstrate responsiveness to the beta-catenin antagonist WNTinib for future drug screening and personalized therapy development.